Intervention
cemiplimab
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownA Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung CancerNCT05800015 · 2023-08-08
ACTIVE_NOT_RECRUITINGA Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT05785767 · 2023-06-30
ACTIVE_NOT_RECRUITINGA Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic CancerNCT04916002 · 2021-11-30
TERMINATEDNeoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult PatientsNCT03916627 · 2019-07-23
ACTIVE_NOT_RECRUITINGStudy of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)NCT03088540 · 2017-05-29
COMPLETEDCommon conditions
Non-Small Cell Lung Cancer3Advanced Non-Small Cell Lung Cancer1Basal Cell Carcinoma1Carcinoma，Non-Small-Cell Lung1Cutaneous Squamous Cell Carcinoma1Head and Neck Squamous Cell Carcinoma1Hepatocellular Carcinoma1Lung Carcinomas, Non-Small-Cell1Merkel Cell Carcinoma1Non-small-cell Lung Carcinoma1Nonsmall Cell Lung Cancer1Oropharynx Squamous Cell Carcinoma1Triple Negative Breast Cancer1
Leading sponsors
Trial status mix
ACTIVE_NOT_RECRUITING3
COMPLETED1
TERMINATED1
Phase mix
PHASE24
PHASE33
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.